title: Differentiation of WEHI-3B D+ monomyelocytic leukemia cells by retinoic acid and aclacinomycin A.
abstract: WEHI-3B D+ monomyelocytic leukemia cells were induced to differentiate to mature granulocytes when treated with either 30 nM aclacinomycin A or 7 microM retinoic acid. Differentiation was assessed by the appearance of mature granulocytic phenotypes, as measured by the ability to reduce nitro blue tetrazolium, morphological changes, an increase in cell surface Fc receptors, as well as the loss of proliferative capacity. Maximum differentiation occurred 3 days after drug exposure. Analysis of DNA histograms of treated cells indicated that cells accumulated in the G1 phase of the cell cycle after 8 h of exposure to either inducer, with maximum accumulation occurring by 20 h; this arrest was observed prior to the phenotypic appearance of mature cells. The minimum interval of time necessary to commit cells to a differentiation pathway, which was less than one doubling time (9.2 h), closely paralleled the initial accumulation of cells in the G1 phase of the cell cycle. Since drug exposure for more than one cell division was required for maximum differentiation, the observed kinetics of maturation is consistent with a stochastic model. These studies support the idea that this cell line would be a particularly good model for extrapolation of findings with differentiating agents in culture to therapeutic monitoring in animals, since WEHI-3B D+ leukemia cells can be readily propagated in vivo in BALB/c mice.
authors.forename: C
authors.initials: C
authors.lastname: Gamba-Vitalo
authors.forename: O C
authors.initials: OC
authors.lastname: Blair
authors.forename: S R
authors.initials: SR
authors.lastname: Keyes
authors.forename: A C
authors.initials: AC
authors.lastname: Sartorelli
mesh_terms: D015250:Aclarubicin; D000818:Animals; D002453:Cell Cycle / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects*; D002460:Cell Line; D004305:Dose-Response Relationship, Drug; D007951:Leukemia, Myeloid / Q000473:pathology*; D051379:Mice; D009279:Naphthacenes / Q000494:pharmacology; D009504:Neutrophils / Q000502:physiology; D011961:Receptors, Fc / Q000378:metabolism; D013997:Time Factors; D014212:Tretinoin / Q000494:pharmacology*
chemical_list: D009279:Naphthacenes; D011961:Receptors, Fc; D014212:Tretinoin; D015250:Aclarubicin